CAMELLA LADD: Open Payments
NPI 1952931693 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 86 payments from 13 companies in 2025. Trend: 2023 $1,639 · 2024 $1,683 · 2025 $2,273
Food & beverage: $2,273
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $497 |
| Novo Nordisk Inc | 17 | $480 |
| GlaxoSmithKline, LLC. | 26 | $296 |
| Lilly USA, LLC | 11 | $271 |
| ABIOMED | 3 | $215 |
| Phathom Pharmaceuticals, Inc. | 4 | $147 |
| Axsome Therapeutics, Inc. | 3 | $128 |
| ABBVIE INC. | 1 | $120 |
| PFIZER INC. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
Products named: Wegovy, TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, Ozempic, VOQUEZNA, Auvelity, KISUNLA.
Industry payments across TX — which companies pay providers there.
